Skip to main content

Advertisement

Log in

Prevalence of yeast in diabetic foot infections

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Diabetic foot infections are a serious threat which cause a long term of hospitalization of diabetes patients and lead to amputations. Hence, prompt diagnosis is an important criterion in the treatment of these infections. This study was carried out to determine the prevalence of yeast in diabetic foot infections. The pus samples were collected from patients presenting with diabetic foot ulcer and processed for microbiological investigation. The patients investigated comprised of 82 males and 78 females. Most of the patients were grade I ulcers followed by grade II ulcers. Out of 160 samples, 138 samples were culture positive, in which yeast isolate Candida glabrata was the predominant isolate followed by Candida albicans, Candida dubliniensis, Candida krusei and Candida tropicalis. C. albicans and C. dubliniensis were differentiated by using tobacco agar due to the presence of hyphal fringes. The methylene blue sabouraud dextrose agar and corn meal agar were also used to differentiate C. albicans from non albicans. The antifungal susceptibility pattern showed 29 % of C. albicans was sensitive to Amphotericin B and Clotrimazole, while 75 % of C. glabrata was sensitive to Amphotericin B, Ketoconazole and Itraconazole. C. dublinensis and C. albicans showed the highest percentage of resistant to Ketoconazole, Fluconazole, Nystatin and Itraconazole. Thus, the results indicating that effective alternate drug of choice are required and the proper selection of antifungal agents will play an important role for the treatment of fungal foot infections. This study will also add substantial knowledge of yeast as one of the pathogenic organisms in diabetic foot infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pappu AK, Sinha A, Johnson A. Microbiological profile of diabetic foot ulcer. Calcutta Med J. 2011;9(3):E2.

    Google Scholar 

  2. Fata S, Saeed Modaghegh M, Faizi R, Najafzadeh M, Afzalaghaee M, Ghasemi M, et al. Mycotic infections in diabetic foot ulcers in Emam Reza Hospital, Mashhad, 2006–2008. Jundishapur J Microbiol. 2011;4(1):1–16.

    Google Scholar 

  3. Durgad S, Koticha A, Nataraj G, Deshpande A, Mehta P. Diabetic foot ulcers—where do we stand microbiologically. Int J Diabetes Dev Ctries. 2014;34(3):169–73.

    Article  Google Scholar 

  4. Chen SC, Marriott D, Playford EG, Nguyen Q, Ellis D, Meyer W, et al. Candidaemia with uncommon Candida Species: predisposing factors, outcome, antifungal susceptibility and implications for management. Clin Microbiol Infect. 2009;15:662–69.

    Article  CAS  PubMed  Google Scholar 

  5. Saunte DML, Holgersen JB, Hadersdal M. Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm Venereol. 2006;86:4258.

    Article  Google Scholar 

  6. Taj-Aldeen SJ, Gent J, Albozom I, Buzina W, Cano JF, Guarro J. Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum. Med Mycol. 2006;44:547–52.

    Article  PubMed  Google Scholar 

  7. Missoni EM, Kalenic S, Vukelic M, De Syo D, Belicza M, Babic V. Candida infections of diabetic foot ulcers. Diabetol Croat. 2005;34(1):29–35.

    Google Scholar 

  8. Chellan G, Shivaprakash S, Vasukutty SR, Bal A, Thekkeparambil Sukumaran HM, Ramaiyar JK, et al. Spectrum and prevalence of fungi infecting deep tissues of lower-limb wounds in patients with type 2 diabetes. J Clin Microbiol. 2010;48(6):2097–102.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nithyalakshmi J, Nirupa S, Sumathi G. Diabetic foot ulcers and Candida co-infection: a single centered study. Int J Curr Microbiol App Sci. 2014;3(11):413–9.

    Google Scholar 

  10. Pereira GH, Muller PR, Szeszs MW, Levin AS, Melhem MS. Five year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-albicans and Candida species. Med Mycol. 2010;48:839–42.

    Article  CAS  PubMed  Google Scholar 

  11. Sardi JCO, Scorzoni L, Bernardi T, Fusco Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62:10–24.

    Article  CAS  PubMed  Google Scholar 

  12. Chander J. Candidiasis—a textbook of medical mycology. Mehta Publishers, New Delhi. 3rd Edition. 2009; 266–90.

  13. Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29:1727–32.

    Article  PubMed  Google Scholar 

  14. Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2:64–72.

    Article  PubMed  Google Scholar 

  15. Priyadarshini S, Jeya M, Linda Susan S. The Bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strains. J Clin Diagn Res. 2013;7(3):441–445.

  16. Manjunath V, Vidya GS, Sharma A, Prakash MR, Murugesh. Speciation of Candida by Hicrome agar and sugar assimilation test in both HIV infected and non infected patients. Int J Biol Med Res. 2012;3(2):1778–82.

    Google Scholar 

  17. Yucesoy M, Esen N, Yulug N. Use of chromogenic tube and methyl blue sabouraud agar for the identification of Candida albicans strains. Kobe J Med Sci. 2001;47:161–7.

    CAS  PubMed  Google Scholar 

  18. Zia Khan U, Ahmad S, Mokaddas E, Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol. 2004;42(10):4796–8.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 11th Edition. 2012; 32: 1

  20. Zubair M, Malik A, Ahmad J. Clinico bacteriology and risk factors for the diabetic foot infection with multidrug resistant microorganisms in north India. Bio Med. 2010;2(4):22–34.

    Google Scholar 

  21. Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T. A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a non-diabetes group from the general population. Qual Life Res. 2007;16:179–89.

    Article  PubMed  Google Scholar 

  22. Hjelm K, Nyberg P, Apelqvist J. Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. J Adv Nurs. 2002;40(6):673–84.

    Article  PubMed  Google Scholar 

  23. Yekta Z, Pourali R, Rad MG. Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers. Diabetes Metab Syndr Obes. 2011;4:393–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Viswanathan, Kumpatla S. Pattern and causes of amputation in diabetic patients—a multicentric study from India. J Ass Phy India. 2011;59:1–8.

    Google Scholar 

  25. Ozer B, Kalaci A, Semerci E, Duran N, Davul S, Yanat AN. Infections and aerobic bacterial pathogens in diabetic foot. Afr J Microbiol Res. 2010;4(20):2153–60.

    Google Scholar 

  26. Ozkara A, Delibas T, Selcoki Y, Arikan MF. The major clinical outcomes of diabetic foot infections: one center experience. Cent Eur J Med. 2005;3(4):464–9.

    Google Scholar 

  27. Oyibo SO, Edward Jude B, Tarawneh I, Hienvu Nguyen C, Lawrence Harkless B, Andrew Boulton JM. A comparison of two diabetic foot ulcer classification systems. Diabetes Care. 2001;24(1):84–8.

  28. Cardino MJT, Cindy Josol V, Tan II, Jimeno C. Risk factors for major amputation of diabetic foot ulcers. Philipp J Intern Med. 2011;49(2):74–8.

  29. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491–4.

    Article  PubMed  Google Scholar 

  30. Sundresh JN, Narendran S, Ramesh R, Kesav jagadeesan, Nasarareddy N. Clinical and microbiological study of diabetic foot in patients admitted at RMMCH, Chidambaram, TamilNadu, India. J Pharma Sci Inov. 2014;3(2):134–8.

  31. Shahi SK, Kumar A, Kumar S, Surya Singh K, Sanjeev Gupta K, Singh TB. Prevalence of diabetic foot ulcer and associated risk factors in diabetic patients from north India. J Diabet Foot Complication. 2012;4(3):83–91.

  32. Anderson J, Boone J, Hansen M, Spencer L, Zflan Fowler BS. A comparison of diabetic smokers and non-smokers who undergo lower extremity amputation: a retrospective review of 112 patients. Diab Foot Ankle. 2012;3:19178.

  33. Chincholikar DA, Pal RB. Study of fungal and bacterial infections of the diabetic foot. Indian J Pathol Microbiol. 2002;45(1):15–22.

    PubMed  Google Scholar 

  34. Heald H, Halloran DJ, Richards K, Webb F, Jenkins S, Hollis S, et al. Fungal infection of the diabetic foot: two distinct syndromes. Diabet Med. 2001;18:567–72.

    Article  CAS  PubMed  Google Scholar 

  35. Bader MS, Lai SM, Kumar V. Candidemia in patients with diabetes mellitus; epidemiology and predictors of mortality. Scand J Infect Dis. 2004;36:860–64.

    Article  PubMed  Google Scholar 

  36. Missoni EM, Radeb D, Nedera S, Kalenic S, Kern J, Babic VV. Differentiation between Candida species isolated from diabetic foot by fatty acid methyl ester analysis using gas chromatography. J Chromatogr. 2005;822:118–23.

    CAS  Google Scholar 

  37. Ajitha R, Mustafa M. Phenotypic identification of Candida species and their susceptibility profile in patients with genitourinary Candidiasis. Int J Adv Res. 2014;2(12):76–84.

  38. Yener S, Comlekci A, Yesil S, Tocpu A, Manisali M. Candida albicans osteomyelitis in a diabetic foot ulcer. J Diabet Complications. 2009;23:137–9.

    Article  Google Scholar 

  39. Sastry AS, Sandhya Bhat K, Sastry AS, Kumudavathi MS. Characterization and susceptibility pattern of Candida isolates from HIV-seropositive patients in a tertiary care Hospital. J Evol Med Dental. 2012;1(4):589–97.

    Article  Google Scholar 

  40. Gandhi TN, Manish Patel G, Mannu JR. Antifungal susceptibility of Candida against six antifungal drugs by disk diffusion method isolated from vulvovaginal candidiasis. Int J Cur Res Rev. 2015;7(11):20–5.

  41. Kothavade RJ, Kura MM, Arvind Valand G, Panthaki MH. Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole. J Med Microbiol. 2010;59:873–80.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Arvind Prasanth.

Ethics declarations

Funding

None.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugandhi, P., Prasanth, D.A. Prevalence of yeast in diabetic foot infections. Int J Diabetes Dev Ctries 37, 50–57 (2017). https://doi.org/10.1007/s13410-016-0491-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-016-0491-8

Keywords

Navigation